Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2014; 20(1): 53-63
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.53
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.53
Table 1 Acquired prothrombotic factors in inflammatory bowel diseases
| Dehydration |
| Glucocorticosteroids therapy |
| Prolonged immobilization |
| Central venous catheters |
| Surgical procedures |
| Oral contraceptives/hormonal replacement therapy |
| Smoking |
| Hyperhomocysteinemia |
Table 2 Changes in coagulation and fibrinolytic systems in patients with in inflammatory bowel diseases
| Coagulation factors | Fibrinolytic factors | Plasma coagulation inhibitors |
| Fibrynogen ↑ | TAFI ↑ | Antithrombin III ↓ |
| Factor V ↑ | PAI-1 ↑ | TFPI ↓ |
| Factor VII ↑ | tPA ↓ | |
| Factor VIII ↑ | ||
| Factor XI ↑ | ||
| Prothrombin fragment 1 + 2 ↑ | ||
| Thrombin-antithrombin complex ↑ | ||
| TF ↑ | ||
| FXIII ↓ |
- Citation: Owczarek D, Cibor D, Głowacki MK, Rodacki T, Mach T. Inflammatory bowel disease: Epidemiology, pathology and risk factors for hypercoagulability. World J Gastroenterol 2014; 20(1): 53-63
- URL: https://www.wjgnet.com/1007-9327/full/v20/i1/53.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i1.53